1020814

Dilawar Ajani, M.D., P.I. — FEI 3007134943

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 17, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)